PT - JOURNAL ARTICLE AU - Young, Taylor AU - Kumar, Vinod Jangid AU - Saranathan, Manojkumar TI - Normative modeling of thalamic nuclear volumes AID - 10.1101/2024.03.06.24303871 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.06.24303871 4099 - http://medrxiv.org/content/early/2024/03/08/2024.03.06.24303871.short 4100 - http://medrxiv.org/content/early/2024/03/08/2024.03.06.24303871.full AB - Thalamic nuclei have been implicated in neurodegenerative and neuropsychiatric disorders. Normative models for thalamic nuclear volumes have not been proposed thus far. The aim of this work was to establish normative models of thalamic nuclear volumes and subsequently investigate changes in thalamic nuclei in cognitive and psychiatric disorders. Volumes of the bilateral thalami and 12 nuclear regions were generated from T1 MRI data using a novel segmentation method (HIPS-THOMAS) in healthy control subjects (n=2374) and non-control subjects (n=695) with early and late mild cognitive impairment (EMCI, LMCI), Alzheimer’s disease (AD), Early psychosis and Schizophrenia, Bipolar disorder, and Attention deficit hyperactivity disorder. Three different normative modelling methods were evaluated while controlling for sex, intracranial volume, and site. Z-scores and extreme z-score deviations were calculated and compared across phenotypes. GAMLSS models performed the best. Statistically significant shifts in z-score distributions consistent with atrophy were observed for most phenotypes. Shifts of progressively increasing magnitude were observed bilaterally from EMCI to AD with larger shifts in the left thalamic regions. Heterogeneous shifts were observed in psychiatric diagnoses with a predilection for the right thalamic regions. Here we present the first normative models of thalamic nuclear volumes and highlight their utility in evaluating heterogenous disorders such as Schizophrenia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementM.S would like to acknowledge funding from the National Institute of Biomedical Imaging and Bioengineering (7R01EB032674)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Only existing public datasets were used in this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe authors will attempt to make all data available upon reasonable request. There may be limitations on the distribution of downstream products from the Human Connectome Project and Alzheimer's Disease Neuroimaging Initiative. https://github.com/thalamicseg/hipsthomasdocker https://www.humanconnectome.org https://adni.loni.usc.edu https://openneuro.org/datasets/ds000030/versions/1.0.0 https://openneuro.org/datasets/ds004302/versions/1.0.1